Guillaume P Nicolas

6PUBLICATIONS
19CO-AUTHORS
Bioavailability and ecotoxicologyTe whakamahi me te hoahoa o te hangarau rorohiko o te Māori (Māori computing technology use and design)Predictive and prognostic markersLiquid biopsiesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 08, 2025
Systematic review and meta-analysis of the efficacy and safety of [177Lu]Lu-edotreotide ([177Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumors.

Richard P Baum, Julia G Fricke, Tristan Ruhwedel

|May 23, 2025
First-in-human administration of [61Cu]Cu-NODAGA-LM3 and head-to-head comparison with [68Ga]Ga-DOTA-TOC PET/CT as part of the phase I/II COPPER PET in NET study.

Guillaume P Nicolas, Manuel Alejandre Lafont, Lisa McDougall

|Jan 11, 2024
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer.

Ivana Bratic Hench, Luca Roma, Floriana Conticelli

|Sep 25, 2023
Augmented reality for sentinel lymph node biopsy.

Peter A von Niederhäusern, Carlo Seppi, Robin Sandkühler

|Mar 10, 2022
Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals.

Melpomeni Fani, Rosalba Mansi, Guillaume P Nicolas

|Dec 24, 2021
Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients.

Deborah Theiler, Marco Cattaneo, Lawrence O Dierickx

Pageof 1

Frequent Collaborators

1 joint publications

Peter A von Niederhäusern

1 joint publications

Carlo Seppi

1 joint publications

Robin Sandkühler

1 joint publications

Philippe C Cattin